1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
- 2023
-
Mark
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
(
- Contribution to journal › Article
- 2022
-
Mark
Inflammatory Animal Models of Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
(
- Contribution to journal › Scientific review
-
Mark
APOE in the bullseye of neurodegenerative diseases : impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Hyperinflammation and Fibrosis in Severe COVID-19 Patients : Galectin-3, a Target Molecule to Consider
(
- Contribution to journal › Article
- 2019
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article